Skip to main content

Table 2 MUC1 expression in endocervical and endometrial adenocarcinomas

From: Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

  Median (range) + Cases/Total (%)1
  ECA EMMA (p-value) ECA EMMA (p-value)
Apical 35 (0–100) 15 (0–90) NS 8/14 (57%) 7/18 (39%) NS
A/C 0 (0–80) 70 (0–100) <0.001 2/14 (14%) 14/18 (78%) <0.001
Negative 35 (0–100) 0 (0–90) 0.01 7/14 (50%) 2/18 (11%) 0.01
  1. ECA, endocervical adenocarcinoma; EMMA, endometrial mucinous adenocarcinoma; A/C, apical/cytoplasmic; NS, not significant. 1 totals are >100% because different areas of tumors differed in staining pattern.